Literature DB >> 26941867

Primary Hepatic Actinomycosis Mimicking Hepatic Malignancy with Metastatic Lymph Nodes by F-18 FDG PET/CT.

Eun Jung Kong1.   

Abstract

Entities:  

Year:  2015        PMID: 26941867      PMCID: PMC4762871          DOI: 10.1007/s13139-015-0345-1

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


× No keyword cloud information.
  7 in total

1.  Primary hepatic actinomycosis.

Authors:  Y C Lakshmana Kumar; Rajesh Javherani; A Malini; S R Prasad
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11       Impact factor: 2.184

Review 2.  Actinomycosis.

Authors:  R A Smego; G Foglia
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

3.  Urachal actinomycosis mimicking a urachal tumor.

Authors:  Kyoung Taek Lim; Seung Jin Moon; Joon Seok Kwon; Young Woo Son; Hong Yong Choi; Yun Young Choi; Ju Yeon Pyo; Yong Wook Park; Hong Sang Moon
Journal:  Korean J Urol       Date:  2010-06-21

4.  [Primary hepatic actinomycosis: a case of inflammatory pseudotumor (case report)].

Authors:  Sadik Tamsel; Gülgün Demirpolat; Refik Killi; Nevra Elmas
Journal:  Tani Girisim Radyol       Date:  2004-06

5.  Abdominal actinomycosis: CT findings in 10 patients.

Authors:  H K Ha; H J Lee; H Kim; H J Ro; Y H Park; S J Cha; K S Shinn
Journal:  AJR Am J Roentgenol       Date:  1993-10       Impact factor: 3.959

Review 6.  Hepatic actinomycosis: an overview of salient features and outcome of therapy.

Authors:  Mamta Sharma; Laurence E Briski; Riad Khatib
Journal:  Scand J Infect Dis       Date:  2002

7.  Hepatic actinomycosis mimicking an isolated tumor recurrence.

Authors:  Michael G Wayne; Rahul Narang; Arif Chauhdry; Justin Steele
Journal:  World J Surg Oncol       Date:  2011-07-11       Impact factor: 2.754

  7 in total
  1 in total

1.  Hepatic actinomycosis with immunoglobulin G4-related liver disease: A case report.

Authors:  Joo Hyung Lee; Hyung Sun Kim; Ji Sub Kim; Dong Ki Lee; Jin Hong Lim
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.